Cervical adenocarcinoma
MONDO:0005153An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.
Also known as: adenocarcinoma - cervix, adenocarcinoma of cervix, adenocarcinoma of cervix uteri, adenocarcinoma of the cervix, adenocarcinoma of the cervix uteri, adenocarcinoma of the uterine cervix, adenocarcinoma of uterine cervix, cervical adenocarcinoma
2882 clinical trials for this condition and its sub-types, 27 tagged with Cervical adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cervical adenocarcinoma
-
Cervical adenosquamous carcinoma 16 trials
1 sub-type
-
Cervical clear cell adenocarcinoma 4 trials
1 sub-type
-
Endocervical adenocarcinoma 3 trials
-
Wolffian duct adenocarcinoma 2 trials
-
Cervical mucinous adenocarcinoma 0 trials · 1 incl. sub-types
6 sub-types
- Endocervical type cervical mucinous adenocarcinoma 1 trial
- Cervical mucinous adenocarcinoma, minimal deviation variant 0 trials
- Cervical villoglandular adenocarcinoma 0 trials
- Intestinal variant cervical mucinous adenocarcinoma 0 trials
- Signet ring cell variant cervical mucinous adenocarcinoma 0 trials
- Uterine ligament mucinous adenocarcinoma 0 trials
-
Cervical adenoid cystic carcinoma 0 trials
-
Cervical endometrioid adenocarcinoma 0 trials
1 sub-type
-
Cervical serous adenocarcinoma 0 trials
1 sub-type
-
Uterine ligament adenocarcinoma 0 trials
4 sub-types
-
Can a higher radiation dose beat cervical cancer without more harm?
Disease control CompletedThis trial tests whether giving a higher radiation dose during brachytherapy, a type of internal radiation, can improve local control in patients with locally advanced cervical cancer. Participants receive standard external beam radiation and chemotherapy, plus a boosted brachyth…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Immunotherapy boosts standard treatment for aggressive cervical cancer
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug atezolizumab before and during standard chemoradiation could help control advanced cervical cancer that has spread to lymph nodes. Forty participants received the combination to see if it activated the immune sys…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Prehabilitation boosts pelvic floor recovery in cervical cancer patients
Symptom relief CompletedThis study tested a 4-week exercise program before surgery (prehabilitation) in 34 women with cervical cancer. The program included aerobic, resistance, and pelvic floor exercises. Results suggest it may improve pelvic floor strength and shorten hospital stays compared to standar…
Sponsor: Saveetha University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC